News | Oncology Diagnostics | December 11, 2015

Study Shows Lymphoseek Reduces Sentinel Lymph Node Biopsy Imaging Time

Data from time-efficiency study presented at RSNA 2015 demonstrates increased patient throughput, workflow efficiencies

Lymphoseek, RSNA 2015, clinical study, sentinel lymph node mapping, SLN

Image courtesy of Navidea Biopharmaceuticals

December 11, 2015 — Navidea Biopharmaceuticals Inc. announced that results from an investigator-initiated imaging study demonstrated Lymphoseek (technetium Tc 99m tilmanocept) injection reduced imaging time by more than 50 percent in sentinel lymph node biopsy procedures in malignant melanoma compared to Tc99m sulfur colloid (SC).

This finding suggests hospitals and oncology treatment teams can achieve greater patient throughput and workflow efficiencies utilizing Lymphoseek. Results of the study — conducted at the Thomas Jefferson University Hospitals and led by Charles M. Intenzo, M.D., professor of radiology, director, nuclear medicine and molecular imaging in the Department of Radiology — were presented at the Radiological Society of North America annual meeting (RSNA 2015) in Chicago.

A total of 34 consecutive patients with malignant melanoma underwent sentinel lymph node (SLN) mapping with Lymphoseek. Patients received the Lymphoseek dose in four intradermal administrations around the tumor site. Images were acquired at intervals up to 40 minutes after injection, which is the department’s standard-of-care protocol used for Tc99m Sulfur Colloid (SC) procedures. This site’s previous experience showed that SC injections required 40 to 45 minutes after injection for visualization of all lymph nodes in patients with malignant melanoma.

Using Lymphoseek, the results show that in all 34 patients, all lymph nodes seen in the final 40-minute image were identified in the 20-minute image, providing rapid and stable localization and identification of the sentinel nodes. The study concludes that in malignant melanoma, SLN mapping with Lymphoseek involves a total imaging time of 20 minutes, which is one-half of the time required for Tc99m SC. From a clinical perspective, the authors conclude that utilizing Lymphoseek is more time-efficient than SC by facilitating patient throughput and expediting subsequent transport to the operating room.

For more information: www.lymphoseek.com

Related Content

Images from computed tomography (CT) colonography show segmented abdominal aortic calcification measured with semiautomated CT tool on coronal image. Within region of interest over aorta selected by user, tool automatically segments and quantifies aortic calcification (shown in blue). 

Image Credit: O’Connor S D, Graffy P M, Zea R, et al. Does nonenhanced CT-based quantification of abdominal aortic calcification outperform the Framingham Risk Score in predicting cardiovascular event sin asymptomatic adults? Radiology doi: 10.1148/radiol.2018180562. Published online Oct. 2, 2018. © RSNA.

News | Computed Tomography (CT) | October 12, 2018
Computed tomography (CT)-based measures of calcification in the abdominal aorta are strong predictors of heart attacks...
CORAR Supports Medicare Diagnostic Radiopharmaceutical Payment Equity Act of 2018
News | Radiopharmaceuticals and Tracers | October 12, 2018
October 12, 2018 — The Council on Radionuclides and Radiopharmaceuticals Inc.
iCAD Announces Positive Clinical Results for Artificial Intelligence Tomosynthesis Technology
News | Mammography | October 11, 2018
iCAD Inc. announced positive clinical results of its new digital breast tomosynthesis (DBT) cancer detection software,...
Carestream Digital X-ray System Deployed at Remote Antarctic Station
News | Digital Radiography (DR) | October 10, 2018
Carestream is providing a DRX-Transportable System/Lite for the Italian-French Concordia scientific station in...
Canon Medical Launches Healthy Sonographer Program
News | Ultrasound Imaging | October 10, 2018
Canon Medical Systems USA Inc. launched an all-new program designed to help reduce the leading causes of pain and...
Huntsman Cancer Institute Installs First Preclinical nanoScan 3T PET/MRI in U.S.
News | PET-MRI | October 10, 2018
The Center for Quantitative Cancer Imaging at Huntsman Cancer Institute (HCI) at the University of Utah in Salt Lake...
FDA Clears Magnetom Sola 1.5T MRI From Siemens Healthineers
Technology | Magnetic Resonance Imaging (MRI) | October 09, 2018
The U.S. Food and Drug Administration (FDA) has cleared the Magnetom Sola, a 1.5 Tesla magnetic resonance imaging (MRI...
Surgery, Radiation Therapy Equally Effective in Treating Oropharyngeal Cancer
News | Radiation Therapy | October 09, 2018
A new study by researchers at UT Southwestern Medical Center found no major long-term differences in the effectiveness...
CHI Franciscan Launches Washington State's First AI-Powered Hospital Mission Control Center
News | Artificial Intelligence | October 08, 2018
CHI Franciscan Health and GE Healthcare have joined forces to implement a NASA-style "Mission Control" command center...
ASTRO 2018 Radiation Therapy Clinical Trials
Feature | ASTRO | October 08, 2018
October 8, 2018 — The American Society for Radiation Oncology (ASTRO) announced the 10 top-rated clinical studies tha